Sourcing 1-(2-Bromoethoxy)-2-ethoxybenzene: A Guide for Manufacturers
For manufacturers in the pharmaceutical and specialty chemical sectors, the reliable sourcing of high-quality intermediates is fundamental to operational success and product integrity. 1-(2-Bromoethoxy)-2-ethoxybenzene, identified by CAS number 3259-03-8, is one such critical compound, primarily utilized as an intermediate in the synthesis of Tamsulosin hydrochloride. Sourcing this chemical effectively involves understanding its specifications, identifying reputable suppliers, and ensuring consistent quality. NINGBO INNO PHARMCHEM CO.,LTD., a prominent manufacturer and supplier based in China, offers this essential intermediate, catering to the global demand for reliable chemical building blocks.
The specifications of 1-(2-Bromoethoxy)-2-ethoxybenzene are key considerations for manufacturers. It is characterized as a white solid with a melting point between 41-43°C and a molecular formula of C10H13BrO2. Crucially, for pharmaceutical applications, a purity level of 95%min is typically required. This purity level ensures that the subsequent synthetic steps proceed efficiently and that the final active pharmaceutical ingredient (API) meets stringent regulatory standards. Manufacturers must ensure that their chosen supplier can consistently deliver material meeting these specifications. NINGBO INNO PHARMCHEM CO.,LTD. prides itself on its quality control processes, guaranteeing that their supply of 1-(2-Bromoethoxy)-2-ethoxybenzene meets the high standards expected by the industry.
When sourcing from China, identifying a reliable manufacturer is paramount. Factors to consider include the supplier's manufacturing capabilities, their adherence to quality management systems (such as ISO certifications), their responsiveness to inquiries, and their track record in the industry. NINGBO INNO PHARMCHEM CO.,LTD. has established itself as a dependable partner, providing not only the chemical itself but also comprehensive support to its clients. Their commitment extends to ensuring timely delivery and providing necessary documentation, such as Certificates of Analysis, which detail the product's properties and purity. This meticulous approach is vital for manufacturers who rely on uninterrupted supply chains and absolute confidence in their raw materials.
The role of 1-(2-Bromoethoxy)-2-ethoxybenzene as an intermediate in the synthesis of Tamsulosin hydrochloride further emphasizes the need for a trustworthy source. Tamsulosin is a significant drug for treating benign prostatic hyperplasia, and its production requires intermediates that are free from detrimental impurities. By partnering with suppliers like NINGBO INNO PHARMCHEM CO.,LTD., manufacturers can mitigate risks associated with inconsistent quality or supply. The competitive pricing offered by Chinese manufacturers, combined with a focus on quality, makes them an attractive global sourcing option. For companies looking to procure this crucial intermediate, engaging with experienced suppliers like NINGBO INNO PHARMCHEM CO.,LTD. is a strategic move towards ensuring production continuity and product excellence.
In conclusion, the successful procurement of 1-(2-Bromoethoxy)-2-ethoxybenzene (CAS 3259-03-8) hinges on careful supplier selection and a thorough understanding of the product's specifications. Manufacturers seeking this vital pharmaceutical intermediate can rely on NINGBO INNO PHARMCHEM CO.,LTD. for a high-quality, consistently pure product, backed by a commitment to customer service and supply chain reliability. Their position as a leading manufacturer in China ensures that global pharmaceutical and chemical companies have access to the essential materials needed to drive innovation and meet market demands.
Perspectives & Insights
Agile Reader One
“It is characterized as a white solid with a melting point between 41-43°C and a molecular formula of C10H13BrO2.”
Logic Vision Labs
“Crucially, for pharmaceutical applications, a purity level of 95%min is typically required.”
Molecule Origin 88
“This purity level ensures that the subsequent synthetic steps proceed efficiently and that the final active pharmaceutical ingredient (API) meets stringent regulatory standards.”